-
11.
公开(公告)号:EP3623367B1
公开(公告)日:2022-09-28
申请号:EP19206925.0
申请日:2015-02-25
发明人: GADHACHANDA, Venkat, Rao , WANG, Qiuping , PAIS, Godwin , HASHIMOTO, Akihiro , CHEN, Dawei , WANG, Xiangzhu , AGARWAL, Atul , DESHPANDE, Milind , WILES, Jason, Allan , PHADKE, Avinash, S.
IPC分类号: C07D401/14 , C07D405/14 , C07D413/14 , A61P37/00 , A61K31/416 , A61K31/401
-
公开(公告)号:EP3494106B1
公开(公告)日:2022-07-20
申请号:EP17757600.6
申请日:2017-08-01
发明人: SHAW, Anthony Adrian
IPC分类号: C07D207/12 , A61K31/401 , A61P43/00
-
公开(公告)号:EP4025208A1
公开(公告)日:2022-07-13
申请号:EP20861629.2
申请日:2020-09-04
申请人: Ebers Tech Inc.
发明人: HOLLAND, Joanne , EBERLIN, Alex
IPC分类号: A61K31/401
-
公开(公告)号:EP3355856B1
公开(公告)日:2022-06-22
申请号:EP16774714.6
申请日:2016-09-27
发明人: REINER, Alberto , REINER, Giorgio
IPC分类号: A61K45/06 , A61K9/16 , A61K9/50 , A61K31/198 , A61K31/401 , A61K31/405 , A61K31/4172 , A23L33/175 , A21D2/24 , A23L33/15 , A23L33/16 , A61K9/20 , A61P3/00
-
公开(公告)号:EP3388427B1
公开(公告)日:2022-01-19
申请号:EP18172389.1
申请日:2014-04-25
发明人: PEREZ, Michel , RILATT, Ian , LAMOTHE, Marie
IPC分类号: C07D401/12 , A61K38/07 , A61K38/40 , C07D417/12 , C07D417/14 , C07D207/08 , C07K5/02 , A61P35/00 , A61K31/401 , A61K31/4025 , A61K31/427 , A61K31/4439
-
公开(公告)号:EP3901164A1
公开(公告)日:2021-10-27
申请号:EP21165677.2
申请日:2013-06-18
IPC分类号: C07K14/335 , A61K31/045 , A61K31/19 , A61K31/198 , A61K31/401 , A61K31/4172 , A61K31/708 , A61K35/747 , A23L33/135 , A23L33/00 , A61K38/16 , A61P1/00 , A61P19/00 , A61P25/00 , A61P29/00 , A61P29/02 , A61P37/00
摘要: The present invention features compositions and methods for treating gluten-related disorders. We describe compositions comprising one or more metabolites produced by Lactobacillus paracasei CBA L74, International Depository Accession Number LMG P- 24778 that reduce cellular entry of gliadin peptides. The compositions may include a physiologically acceptable carrier, for example, a food product or a pharmaceutical carrier. The compositions can be administered to a subj ect having a gluten-related disorder, for example, celiac disease or gluten sensitivity.
-
公开(公告)号:EP3888651A1
公开(公告)日:2021-10-06
申请号:EP19888637.6
申请日:2019-11-29
IPC分类号: A61K31/40 , A61K31/401 , A61K31/4174 , A61K31/422 , A61K31/437 , A61K31/4439 , A61K31/444 , A61P35/00 , A61P35/04 , A61P43/00 , C07D207/36 , C07D233/78 , C07D401/10 , C07D401/12 , C07D405/06 , C07D413/04 , C07D471/04 , C07D213/71 , C07D213/73
摘要: Provided is a compound that is usable as an active ingredient of an anticancer agent. Preferably provided is a compound that has DOCK1-inhibiting activity and exerts an anticancer effect based on the activity. A compound represented by the following formula (A) or a salt thereof:
wherein
X represents a carbon atom or a nitrogen atom;
Y represents an oxygen atom, a hydroxy group, or a hydrocarbon group;
R 1 and R 2 are different, and each represents a hydrogen atom or a group represented by the following formula (A-1):
(wherein R 6 represents a pyrrolidino group or a phenyl group, and n 2 is 0 or 1) ;
R 3 represents -CO-R 7 (wherein R 7 is an alkoxy group, an alkyl group, or an alkylamino group), a 1,3-oxazole group, an alkylhydroxy group, a hydrogen atom, or an oxygen atom;
R 4 represents a hydrogen atom, an oxygen atom, or a hydrocarbon group in which one or more hydrogen atoms may be replaced by one or more substituents;
R 5 represents a halogen atom, a halogenated alkyl group, or a halogenated alkylthio group; and
n 1 is an integer of 0 to 5; and-
公开(公告)号:EP3883560A1
公开(公告)日:2021-09-29
申请号:EP19820867.0
申请日:2019-11-18
IPC分类号: A61K31/337 , A61K31/401 , A61K31/513 , A61K33/24 , A61K38/00 , A61K38/16 , A61K45/06 , A61P35/00 , C07K14/42
-
公开(公告)号:EP3223807B1
公开(公告)日:2021-09-15
申请号:EP15862576.4
申请日:2015-11-24
IPC分类号: A61K31/401 , A61P11/00 , C07D207/08
-
公开(公告)号:EP3873453A1
公开(公告)日:2021-09-08
申请号:EP19879930.6
申请日:2019-10-30
IPC分类号: A61K31/198 , A61K31/401 , A61P11/00 , A61P43/00
-
-
-
-
-
-
-
-
-